Hindustan Bio Sciences Ltd

Hindustan Bio Sciences Ltd

$HINDBIOSoftware ProductsBSE

Hindustan Bio Sciences Ltd (HINDBIO) last traded at ₹7.24, a market capitalisation of ₹7.44 crore. Over the past 52 weeks the stock has ranged between ₹5 and ₹9.92. Hindustan Bio Sciences Ltd last reported results for the quarter ended Jun 2026, with sales of ₹0 crore and net profit of ₹-0.11 crore. Figures are as of 25 Aug 2026 and are not real time.

Hindustan Bio Sciences Ltd share price and key metrics

Current price
₹7.24
Market cap
₹7.44 cr
Book value
₹0.81
ROE
-9.25%
ROCE
-2.43%
Dividend yield
0.00%
52w high / low
9.92/5.00

Metrics as of 25 Aug 2026. Not real time.

Hindustan Bio Sciences Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹0 cr, down 100.0% from ₹0.32 cr a year earlier. Net profit swung to a loss of ₹0.11 cr.

Hindustan Bio Sciences Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales0.4100.380.3200.3800
Expenses0.340.040.280.320.060.310.110.11
Operating profit0.07-0.040.10-0.060.07-0.11-0.11
OPM %17.07%26.32%0.00%18.42%
Other income0.0100.010.010.010.0200
Interest00000000
Depreciation000000.0100
Profit before tax0.08-0.040.110.01-0.050.08-0.11-0.11
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net profit0.08-0.040.110.01-0.060.08-0.12-0.11
EPS (₹)0.08-0.040.110.01-0.060.08-0.12-0.11

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Hindustan Bio Sciences Ltd annual results

Hindustan Bio Sciences Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1.030.430.921.050.810.740.38
Operating profit-0.94-0.51-0.030.060.1-0.06-0.21
OPM %-91.26%-118.60%-3.26%5.71%12.35%-8.11%-55.26%
Net profit-0.94-0.52-0.040.060.1-0.08-0.21
EPS (₹)-0.92-0.51-0.040.060.10-0.08-0.21

TTM is the trailing twelve months to the most recent quarter.

Hindustan Bio Sciences Ltd growth and returns

Compounded Sales Growth
10 Years
-5%
5 Years
-6%
3 Years
-7%
TTM
-66%
Compounded Profit Growth
10 Years
4%
5 Years
14%
3 Years
%
TTM
-231%
Stock Price CAGR
10 Years
15%
5 Years
13%
3 Years
5%
1 Year
-17%
Return on Equity
10 Years
-22%
5 Years
-11%
3 Years
3%
Last Year
-9%

Hindustan Bio Sciences Ltd shareholding pattern

Promoters held 12.19% at Jun 2026, broadly unchanged since Jun 2025.

Hindustan Bio Sciences Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters12.19%12.19%12.19%12.19%12.19%12.19%12.19%12.19%
Public87.81%87.82%87.80%87.81%87.81%87.81%87.80%87.81%
No. of shareholders11,61811,27611,24611,62011,40511,51611,53011,707

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Track Hindustan Bio Sciences Ltd

Cruxal reads every Hindustan Bio Sciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Hindustan Bio Sciences Ltd (HINDBIO) Results, Financials & Share Price | Cruxal